The Biomarker: Melanoma
PMO is pleased to offer the department “The Biomarker†to discuss the identification of biomarkers in patients with cancer and the prognostic/predictive impact and clinical decision-making implications of that marker. This month, we focus on KIT mutations in melanoma patients. Dr Sanjiv Agarwala provides his insights on this provocative topic.
Video Categories: The Biomarker